Condition
H Pylori Gastritis
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Unknown1
Active Not Recruiting1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07224035Phase 4Active Not Recruiting
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1
NCT07179237Phase 2RecruitingPrimary
Efficacy of Carminal in Helicobacter Pylori Gastritis
NCT04721704Not ApplicableUnknownPrimary
Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children
Showing all 3 trials